Seroprevalence of pediatric malaria in quetta, balochistan, pakistan

K Hussain1, M Shafee, N Khan

  • 1Microbiology Section, Children Hospital, Quetta, Pakistan.

Insights

Pediatric malaria is a significant health concern in Quetta, Pakistan, with Plasmodium vivax being the most common species. Urgent control programs are needed to address this prevalent disease.

Area of Science:

  • Medical Parasitology
  • Pediatric Infectious Diseases
  • Public Health Entomology

Background:

  • Malaria is a major protozoal disease in developing nations, particularly Pakistan, with scarce health resources.
  • Pakistan reports 4.5 million suspected malaria cases annually, highlighting its public health burden.
  • The study focuses on pediatric malaria incidence in Quetta, Balochistan, a region with limited healthcare access.

Purpose of the Study:

  • To determine the incidence and prevalence of malaria in children in Quetta, Balochistan.
  • To identify the predominant Plasmodium species causing malaria in the pediatric population.
  • To analyze malaria distribution across different age groups and seasons in the study area.

Main Methods:

  • A cross-sectional study was conducted at Children Hospital Quetta (CHQ) from July 2011 to March 2012.
  • Blood samples were collected from 3418 clinically suspected pediatric malaria cases.
  • Giemsa-stained thin and thick blood films were used for microscopic examination to detect malarial parasites.

Main Results:

  • Out of 3418 children, 230 (6.72%) tested positive for malaria.
  • Plasmodium vivax (54.34%) was more prevalent than Plasmodium falciparum (44.78%).
  • Male children (65.21%) were more commonly affected than females (34.78%), with peak prevalence in summer.

Conclusions:

  • The study reveals a high prevalence of pediatric malaria in Quetta, Pakistan, indicating a substantial public health threat.
  • Plasmodium vivax is the dominant malaria parasite in the pediatric population of Quetta.
  • There is an urgent need for targeted malaria control programs in Quetta to mitigate the disease's impact.
Abstract